Compare ATI & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATI | DXCM |
|---|---|---|
| Founded | 1960 | 1999 |
| Country | United States | United States |
| Employees | 7600 | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 28.1B |
| IPO Year | 1996 | 2005 |
| Metric | ATI | DXCM |
|---|---|---|
| Price | $197.99 | $74.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | ★ $153.75 | $85.33 |
| AVG Volume (30 Days) | 1.5M | ★ 6.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.76 | ★ 47.18 |
| EPS | ★ 0.85 | 0.51 |
| Revenue | ★ $4,043,500,000.00 | N/A |
| Revenue This Year | $9.52 | $14.46 |
| Revenue Next Year | $9.02 | $12.31 |
| P/E Ratio | $233.94 | ★ $147.96 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $70.42 | $54.11 |
| 52 Week High | $199.04 | $89.07 |
| Indicator | ATI | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 72.77 | 61.06 |
| Support Level | $141.00 | $62.86 |
| Resistance Level | N/A | $81.64 |
| Average True Range (ATR) | 7.47 | 2.87 |
| MACD | 2.29 | 0.07 |
| Stochastic Oscillator | 85.47 | 55.21 |
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.